Medical Director - Heart, Vessel, Blood
Vallerie McLaughlin is the Kim A. Eagle MD Endowed Professor of Cardiovascular Medicine at the University of Michigan, Ann Arbor, MI, USA, Director of the Pulmonary Hypertension Program. She received her MD from Northwestern University Medical School, Chicago, IL, USA, in 1989. This was followed by a residency and internship at the University of Michigan Hospitals, Ann Arbor, (1989–1992), and a Cardiology Fellowship at Northwestern University, Chicago (1992–1995). She is a Fellow of the American College of Cardiology, American College of Chest Physicians and the American Heart Association (AHA) (clinical cardiology and epidemiology). Dr. McLaughlin has been the Principal Investigator of several major clinical trials of drug therapies for pulmonary arterial hypertension and has published numerous papers in this field. She is an editorial board member of Chest, a Guest Editor for the Journal of the American College of Cardiology and is a past Editor-in-Chief of Advances in Pulmonary Hypertension. She is a past chair of the Scientific Leadership Committee and immediate past Chair of the Board of Trustees of the Pulmonary Hypertension Association, has chaired the American College of Cardiology Foundation/AHA Clinical Expert Consensus Document Committee for Pulmonary Arterial Hypertension, and is the Chair of the Cardiovascular Medical Research and Education Fund Steering Committee.